首页> 外国专利> REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION BY THE USE OF HUMAN MESENCHYMAL STEM CELLS

REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION BY THE USE OF HUMAN MESENCHYMAL STEM CELLS

机译:通过使用人类间充质干细胞来调节造血干细胞的分化

摘要

The invention relates to the induction of hematopoietic stem cells to differentiate into osteoclasts by culturing hematopoietic stem cells with human mesenchymal stem cells, and, in a preferred embodiment, using no exogenous cytokines. Differentiation of the mesenchymal stem cells into osteoblasts inhibited the differentiation of hematopoietic stem cells into osteoclasts. In addition, hematopoietic stem cells can be genetically engineered to carry genes of interest particularly for the expression of physiologically active proteins. In the presence of mesenchymal stem cells, the transduced cells carry the new genetic material and express gene products that can be used to modulate bone resorption.
机译:本发明涉及通过与人间充质干细胞一起培养造血干细胞,并且在一个优选的实施方案中,不使用外源细胞因子来诱导造血干细胞分化为破骨细胞。间充质干细胞向成骨细胞的分化抑制了造血干细胞向破骨细胞的分化。另外,可以对造血干细胞进行基因工程改造,使其携带感兴趣的基因,尤其是用于表达生理活性蛋白的基因。在间充质干细胞的存在下,转导的细胞携带新的遗传物质并表达可用于调节骨吸收的基因产物。

著录项

  • 公开/公告号PT1084230E

    专利类型

  • 公开/公告日2008-01-25

    原文格式PDF

  • 申请/专利权人 OSIRIS THERAPEUTICS INC.;

    申请/专利号PT19990955496T

  • 发明设计人 MARK A. THIEDE;GABRIEL MBALAVIELE;

    申请日1999-06-08

  • 分类号A61K35/12;A61K48;A61P19;C12N5/078;C12N5/10;

  • 国家 PT

  • 入库时间 2022-08-21 20:06:21

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号